← Browse by Condition
Medical Condition
chronic pain management
Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
Chronic pain research has gained urgency given the limitations of opioid therapy and the search for non-addictive alternatives. Nav1.7 and Nav1.8 sodium channel blockers, CGRP antagonists (extended from migraine to other pain conditions), and neuromodulation approaches represent the most active mechanistic targets in current trials.
Trials investigate suzetrigine (Nav1.8 blocker), ziconotide intrathecal delivery, spinal cord stimulation with novel waveforms (burst, high-frequency), ketamine infusion protocols, low-dose naltrexone, and psychedelic-assisted pain management. Digital pain measurement tools and PROMIS scales are increasingly validated as primary endpoints.
Frequently Asked Questions — chronic pain management Clinical Trials
How many clinical trials are currently recruiting for chronic pain management?
ClinicalMetric currently tracks 1 actively recruiting clinical trials for chronic pain management, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 1. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic pain management?
chronic pain management research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic pain management clinical trial?
Eligibility criteria for chronic pain management trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 1
Top Sponsors
1 trial
Recruiting Clinical Trials
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology